"The Psychosocial: Family Impact Grants will support studies by established investigators that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. These grants are designed to fund researchers who have novel approaches to understanding the psychosocial aspects of pediatric cancer whose proposals will have clinically significant impact. "
Deadline for letter of intent: July 20, 2016Read More
The PATH program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. The goal of the program is to provide opportunities for accomplished investigators still early in their careers to study what happens at the points where the systems of humans and potentially infectious agents connect. The program supports research that sheds light on the fundamentals that affect the outcomes of these encounters: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones.
Deadline: July 15, 2016Read More
Quality of Life Research Grants have been created to support quality of life cancer research that has the potential to make a significant impact on the burden of disease in patients, survivors and caregivers. These grants are intended to explore psychosocial, survivorship, symptom control, supportive care and end-of-life issues, research gaps, needs and opportunities, or models for survivorship care. The grants are meant to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will result in the reduced burden or enhanced quality of life for cancer patients in Canada and elsewhere.
Deadline for letter of intent: June 29, 2016Read More
Supports early stage pilot clinical trials of candidate therapeutics or interventions for treatment of manifestations of NF1, NF2 and schwannomatosis. In addition, these awards support innovative clinical trial enabling studies.
Deadline for pre-applications: June 20, 2016Read More
The Autism Research Program focuses on ways to improve diagnosis, treatment, and studying psychosocial factors for affecting key life time transitions to independence and a better life for those with autism and their families. The FY 2016 program includes two funding mechanisms: Clinical Trial Awards; and Idea Development Awards.
Deadline for Pre-Application: June 22, 2016Read More
The GWIRP focuses on funding innovative, competitively peer-reviewed research to (1) provide a better understanding of the pathobiology underlying GWI, (2) identify objective markers (biomarkers) for improved diagnosis, and (3) to develop treatments for the complex of GWI symptoms and their underlying causes.
Deadlines for Pre-Application: July 15, 2016Read More
The LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer.
Deadline for pre-applications: June 9, 2016Read More
The NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis.
"Deadline for pre-applications for Clinical Consortiums: June 8, 2016 Deadline for pre-applications, all other award mechanisms: July 18, 2016"Read More
"The FY16 PRMRP Topic Areas are listed below. • Acute Lung Injury • Antimicrobial Resistance • Chronic Migraine and Post-Traumatic Headache • Congenital Heart Disease • Constrictive Bronchiolitis • Diabetes • Dystonia • Emerging Infectious Diseases • Focal Segmental Glomerulosclerosis • Fragile X Syndrome • Hepatitis B • Hereditary Angioedema • Hydrocephalus • Inflammatory Bowel Disease • Influenza • Integrative Medicine • Interstitial Cystitis • Lupus • MalariaMetals Toxicology • Mitochondrial Disease • Nanomaterials for Bone Regeneration • Non-Opioid Pain Management • Pancreatitis • Pathogen-Inactivated Dried Plasma • Polycystic Kidney Disease • Post-Traumatic Osteoarthritis • Psychotropic Medications • Pulmonary Fibrosis • Respiratory Health • Rett Syndrome • Rheumatoid Arthritis • Scleroderma • Sleep Disorders • Tinnitus • Tuberculosis • Vaccine Development for Infectious Disease • Vascular Malformations • Women’s Heart Disease"
"Deadline for pre-applications for Clinical Trial Awards and Focused Program Awards: June 29, 2016 Deadline for pre-applications for Discovery Award: July 7, 2016 Deadline for pre-applications for Investigator-Initiated Research Awards and Technology/Therapeutic Development Award: June 23, 2016"Read More
"The vision of the PH/TBIRP is to prevent, mitigate, and treat the effects of traumatic stress and TBI on function, wellness, and overall quality of life for Service members as well as their caregivers and families. The JPC-5/MOMRP is seeking applications for the FY16 PH/TBIRP Cognitive Resilience and Readiness Research Award (CR3A). The general focus of this Program Announcement/Funding Opportunity is to build and sustain cognitive resilience in Service members and to ensure short- and long-term readiness of the force. "
Deadline for Pre-Application (Preproposal): June 27, 2016Read More
The SCIRP focuses its funding on innovative projects that have the potential to make a significant impact on improving the function, wellness, and overall quality of life for military service members as well as their caregivers, families, and the American public.
Deadline for Pre-Application (Preproposal): June 21, 2016Read More
To encourage innovative research aimed at understanding the pathogenesis and manifestations of TSC to improve the lives of individuals with TSC.
Deadline for pre-applications: July 1, 2016Read More
The LAM Foundation offers funding for research by new and established investigators into Lymphangioleiomyomatosis (LAM).
Deadline for letter of intent: July 15, 2016Read More
"The Lung Cancer Research Foundation is proud to fund research that they believe will make major contributions toward better treatments, screening, and prevention of lung cancer. "
Deadline: July 1, 2016Read More
"The National Ataxia Foundation (NAF) is committed to funding the best science relevant to hereditary and sporadic types of ataxia in both basic and translational research. Funding for Ataxia-Telangiectasia research proposals will receive a lower priority unless they lend themselves to an overall better understanding of the ataxia disease process. "
Deadlines for letters of intent vary by competition - see website.Read More
The Saving tiny Hearts Society’s mission is to raise seed money for grossly under-funded, lifesaving grass roots research of congenital heart defects (CHD's).
Deadline: July 1, 2016Read More
Researchers can submit applications to access stored blood, urine and DNA biospecimens from the Canadian Health Measures Survey (CHMS).
Deadlines: June 30, 2016Read More
"The purpose of the Vasculitis Foundation Research Program is to provide one- or two-year seed grants to support pilot studies in researching:
- Etiology/Pathogenesis (could include a broad range of studies of immunity, inflammation, or vascular biology. Relevance to human vasculitis will be taken into account by the reviewers.)
- Epidemiology, including genetics.
- Diagnosis, including identification of disease subtypes.
- Treatment/Management, including therapeutics to treat vasculitis or prevent complications, biomarkers, and psychosocial outcomes. "
Deadline: September 5, 2016Read More
The VHL Alliance is pleased to announce a call for applications for research grant support on topics relevant to von Hippel-Lindau disease. Projects should further the understanding of VHL disease and may address VHL cell and molecular biology, the development and/or application of VHL-relevant animal models, or the diagnosis and treatment of VHL patients.
Deadline for letter of Intent: June 1, 2016Read More
The Weston Brain Institute is delighted to launch our Canada: Rapid Response 2016 program to provide seed funding for novel, high-risk, high-reward translational research. NEW for 2016: The program will have 3 application rounds, focused on two different disease groups. Applicants should apply to the group best suited to their project. Each PI may submit one application per round as the Principal Applicant or the Administrative Supervisor.
"Deadline for letter of intent for Round 2: PD-related diseases (PD, PSP, DLB, MSA and prodromes) : June 27, 2016 Deadline for letter of intent Round 3: AD-related diseases (AD, FTD, MCI and prodromes): July 28, 2016"Read More
Western researchers can consult Pivot, a comprehensive database of grant information.